← Back to Screener
Adagio Medical Holdings, Inc Common Stock (ADGM)
Price$1.48
Favorite Metrics
Price vs S&P 500 (26W)-40.43%
Price vs S&P 500 (4W)35.76%
Market Capitalization$31.76M
All Metrics
Book Value / Share (Quarterly)$0.56
P/TBV (Annual)4.05x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.87
Price vs S&P 500 (YTD)34.86%
EPS (TTM)$-1.58
10-Day Avg Trading Volume0.32M
EPS Excl Extra (TTM)$-1.58
EPS (Annual)$-1.51
ROI (Annual)-75.01%
Gross Margin (Annual)-451.16%
Cash / Share (Quarterly)$0.77
ROA (Last FY)-57.99%
EBITD / Share (TTM)$-1.25
Cash Flow / Share (Annual)$-0.87
P/B Ratio2.56x
P/B Ratio (Quarterly)1.78x
Net Income / Employee (Annual)$-0
Net Interest Coverage (TTM)-6.40x
ROA (TTM)-66.00%
EPS Incl Extra (Annual)$-1.51
Current Ratio (Annual)2.44x
Quick Ratio (Quarterly)2.12x
3-Month Avg Trading Volume0.15M
52-Week Price Return77.31%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.24
P/S Ratio (Annual)52.76x
Asset Turnover (Annual)0.01x
52-Week High$2.87
EPS Excl Extra (Annual)$-1.51
26-Week Price Return-36.44%
Quick Ratio (Annual)2.12x
13-Week Price Return52.45%
Total Debt / Equity (Annual)1.70x
Current Ratio (Quarterly)2.44x
Enterprise Value$35.696
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-12465.28%
Cash / Share (Annual)$0.77
3-Month Return Std Dev93.05%
Net Income / Employee (TTM)$-0
ROE (Last FY)-202.26%
EPS Basic Excl Extra (Annual)$-1.51
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)1.70x
EPS Incl Extra (TTM)$-1.58
ROI (TTM)-50.39%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.24
Price vs S&P 500 (52W)47.48%
Year-to-Date Return37.50%
5-Day Price Return1.42%
EPS Normalized (Annual)$-1.51
ROA (5Y Avg)-150.53%
Net Profit Margin (Annual)-12465.28%
Month-to-Date Return24.35%
EBITD / Share (Annual)$-1.25
Operating Margin (Annual)-13980.07%
LT Debt / Equity (Annual)1.70x
LT Debt / Equity (Quarterly)1.70x
EPS Basic Excl Extra (TTM)$-1.58
P/TBV (Quarterly)4.05x
P/B Ratio (Annual)1.78x
Inventory Turnover (TTM)0.32x
Book Value / Share (Annual)$0.56
Price vs S&P 500 (13W)51.76%
Beta0.15x
Revenue / Share (TTM)$0.00
ROE (TTM)-134.16%
52-Week Low$0.74
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.14
4.14
4.14
Industry Peers — Surgical & Medical Instruments(109)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ADGMAdagio Medical Holdings, Inc Common Stock | — | — | — | — | $1.48 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
Adagio Medical Holdings develops cryoablation catheter systems for treating cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia. The company's proprietary technology creates contiguous, transmural lesions designed to improve treatment durability and patient outcomes. Adagio addresses both paroxysmal and persistent arrhythmias, targeting a substantial portion of the cardiac electrophysiology market.